Q2 2023 Everest Medicines Ltd Earnings Call (English) Transcript
Good morning, and welcome to Everest Medicines 2023 Interim Results Conference Call. Please be advised that today's conference is being recorded. (Operator Instructions)
At this time, I would like to hand the conference over to your speaker today, Ms. Leah Liu, VP of Corporate Affairs. Please go ahead.
Thank you Operator. Good morning, everybody, and welcome to our 2023 interim financial results conference call. Joining us today are Mr. Rogers Luo, CEO of Everest Medicines. Mr. Ian Woo, President and CFO; Dr. Zhengying Zhu, our Chief Medical Officer; and Dr. Jennifer Yang, our Chief Scientific Officer.
Before we get started, I'd like to remind you that the speakers on this conference call may make statements that constitute forward-looking statements, including descriptions regarding the intent, belief or current expectations of the company or its officers with respect to business operations and financial conditions of the company, which can be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |